2013 BRFSS Asthma Call-Back Survey Prevalence Tables
TABLE 10. Estimated percent using inhaled short acting beta agonists among adults1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey Land Line Sample, United States, 2013
| State/Territory | Current | Active | ||||||
|---|---|---|---|---|---|---|---|---|
| Sample size± |
% | SE§ | 95% CI† | Sample size |
% | SE | 95% CI | |
| Alabama | 129 | 60.6 | 7.7 | (45.5 – 75.7) | 138 | 52.9 | 8.5 | (36.2 – 69.6) |
| Arizona | 103 | 52.4 | 10.8 | (31.2 – 73.6) | 105 | 54.6 | 10.6 | (33.8 – 75.4) |
| California | 168 | 52.0 | 7.2 | (37.9 – 66.1) | 184 | 55.1 | 6.1 | (43.1 – 67.1) |
| Connecticut | 212 | 60.6 | 6.2 | (48.4 – 72.8) | 232 | 57.5 | 6.1 | (45.5 – 69.5) |
| Florida | 724 | 52.1 | 5.7 | (40.9 – 63.3) | 767 | 54.3 | 5.4 | (43.7 – 64.9) |
| Georgia | 122 | 35.1 | 7.0 | (21.4 – 48.8) | 132 | 35.3 | 6.8 | (22.0 – 48.6) |
| Hawaii | 110 | 56.5 | 9.1 | (38.7 – 74.3) | 110 | 55.2 | 10.0 | (35.6 – 74.8) |
| Indiana | 319 | 61.8 | 5.0 | (52.0 – 71.6) | 334 | 60.8 | 4.8 | (51.4 – 70.2) |
| Iowa | 208 | 41.0 | 7.3 | (26.7 – 55.3) | 212 | 42.2 | 6.9 | (28.7 – 55.7) |
| Kansas | 627 | 55.9 | 3.9 | (48.3 – 63.5) | 655 | 57.1 | 3.8 | (49.7 – 64.5) |
| Kentucky | 334 | 55.6 | 5.2 | (45.4 – 65.8) | 363 | 49.8 | 5.0 | (40.0 – 59.6) |
| Louisiana | 125 | 46.3 | 7.6 | (31.4 – 61.2) | 144 | 45.5 | 9.3 | (27.3 – 63.7) |
| Maine | 223 | 58.8 | 5.9 | (47.2 – 70.4) | 240 | 55.4 | 5.7 | (44.2 – 66.6) |
| Maryland | 225 | 43.6 | 6.0 | (31.8 – 55.4) | 243 | 41.9 | 5.7 | (30.7 – 53.1) |
| Massachusetts | 142 | 38.9 | 9.0 | (21.3 – 56.5) | 151 | 38.1 | 8.3 | (21.8 – 54.4) |
| Michigan | 461 | 55.6 | 4.4 | (47.0 – 64.2) | 494 | 53.9 | 4.2 | (45.7 – 62.1) |
| Mississippi | 214 | 40.7 | 7.2 | (26.6 – 54.8) | 217 | 41.6 | 7.4 | (27.1 – 56.1) |
| Missouri | 213 | 56.9 | 6.5 | (44.2 – 69.6) | 220 | 57.5 | 6.4 | (45.0 – 70.0) |
| Montana | 257 | 50.8 | 8.4 | (34.3 – 67.3) | 275 | 48.4 | 8.1 | (32.5 – 64.3) |
| Nebraska | 262 | 48.4 | 9.1 | (30.6 – 66.2) | 283 | 45.2 | 8.3 | (28.9 – 61.5) |
| Nevada | 100 | 39.9 | 9.0 | (22.3 – 57.5) | 115 | 49.5 | 9.7 | (30.5 – 68.5) |
| New Hampshire | 216 | 51.8 | 6.6 | (38.9 – 64.7) | 228 | 48.8 | 6.7 | (35.7 – 61.9) |
| New Jersey | 251 | 39.3 | 5.8 | (27.9 – 50.7) | 282 | 32.9 | 5.1 | (22.9 – 42.9) |
| New Mexico | 223 | 53.6 | 6.1 | (41.6 – 65.6) | 238 | 53.3 | 6.1 | (41.3 – 65.3) |
| New York | 112 | 41.7 | 8.1 | (25.8 – 57.6) | 112 | 47.3 | 7.9 | (31.8 – 62.8) |
| North Carolina | 106 | 62.7 | 7.8 | (47.4 – 78.0) | 124 | 56.9 | 7.9 | (41.4 – 72.4) |
| Ohio | 244 | 52.8 | 6.1 | (40.8 – 64.8) | 256 | 52.4 | 5.8 | (41.0 – 63.8) |
| Oklahoma | 222 | 55.8 | 6.0 | (44.0 – 67.6) | 231 | 59.4 | 5.6 | (48.4 – 70.4) |
| Oregon | 161 | 57.2 | 7.7 | (42.1 – 72.3) | 178 | 56.7 | 7.4 | (42.2 – 71.2) |
| Pennsylvania | 247 | 61.2 | 5.8 | (49.8 – 72.6) | 265 | 53.9 | 5.8 | (42.5 – 65.3) |
| Rhode Island | 196 | 45.6 | 7.0 | (31.9 – 59.3) | 208 | 47.8 | 6.9 | (34.3 – 61.3) |
| Texas | 208 | 46.7 | 7.8 | (31.4 – 62.0) | 231 | 45.3 | 7.3 | (31.0 – 59.6) |
| Utah | 303 | 58.2 | 6.0 | (46.4 – 70.0) | 320 | 55.0 | 5.9 | (43.4 – 66.6) |
| Vermont | 189 | 67.4 | 6.0 | (55.6 – 79.2) | 201 | 67.7 | 5.8 | (56.3 – 79.1) |
| Washington | 286 | 51.2 | 6.3 | (38.9 – 63.5) | 294 | 55.8 | 5.9 | (44.2 – 67.4) |
| West Virginia | 125 | 51.6 | 6.0 | (39.8 – 63.4) | 125 | 52.8 | 6.0 | (41.0 – 64.6) |
| Wisconsin | 188 | 58.0 | 6.9 | (44.5 – 71.5) | 190 | 52.9 | 8.6 | (36.0 – 69.8) |
| Puerto Rico | 205 | 55.0 | 6.3 | (42.7 – 67.3) | 246 | 46.0 | 6.1 | (34.0 – 58.0) |
| 38 state total | 8,760 | 50.8 | 1.7 | (47.5 – 54.1) | 9,343 | 50.6 | 1.5 | (47.7 – 53.5) |
| Median | 52.6 | 52.9 | ||||||
| Range | 35.1-67.4 | 32.9-67.7 | ||||||
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
± Landline sample size excludes “DK/Refused”
§ Standard error
† Confidence interval
Page last reviewed: June 5, 2015